Rheumatoid arthritis Trials in Rome, Italy
Conditions / Rheumatoid arthritis / Rome, Italy
Clinical trials for Rheumatoid arthritis investigate a range of treatment strategies and patient populations.
23 total trials for this combination
Showing top 10 of 23 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01007435 | A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT02198651 | A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects | COMPLETED | PHASE4 |
| NCT01721044 | A Moderate to Severe Rheumatoid Arthritis Study | COMPLETED | PHASE3 |
| NCT01543503 | An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis | COMPLETED | — |
| NCT00208455 | A Multi-centre Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement | TERMINATED | PHASE4 |
| NCT01636843 | A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate | TERMINATED | PHASE2 |
| NCT01636817 | A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics | TERMINATED | PHASE2 |
| NCT01476956 | Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography | COMPLETED | — |
| NCT00234884 | Post-marketing Observational Study in Subjects With Rheumatoid Arthritis | COMPLETED | — |
| NCT05869955 | A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1) | RECRUITING | PHASE1 |